LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

LLY

1,125.18

+4.16%↑

JNJ

228.23

+2.11%↑

ABBV

224.88

+3.55%↑

UNH

396.79

+4.98%↑

MRK

120.25

+4.69%↑

Home・Listă Acțiuni・Waters Corp

Waters Corp

Închisă

SectorSănătate

376.89 -0.73

Cumpără Vinde

Rezumat

Modificarea prețului

24h

Curent

Minim

374.63

Maxim

383.85

Indicatori cheie
By Trading Economics
Venit	-297M -72M
Vânzări	335M 1.3B
P/E Medie Sector	48.112 49.888
EPS	2.7
Marjă de profit	-5.683
Angajați	16,000
EBITDA	-219M 106M

Recomandări
By TipRanks
Recomandări	Cumpărare
Prognoză pe 12 luni	+2.4% upside

Dividende
By Dow Jones
Următoarele câștiguri	3 aug. 2026

Statistici piață
By TradingEconomics
Capitalizare de piață	7.5B 37B
Deschiderea anterioară	377.62
Închiderea anterioară	376.89

Sentimentul știrilor

By Acuity

29%

71%

67 / 344 Clasament în Healthcare

Waters Corp Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

14 iul. 2025, 14:26 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5 Billion Deal -- 2nd Update

14 iul. 2025, 11:08 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson Unit to Combine With Waters Corp. in $17.5 Billion Deal -- Update

15 iul. 2025, 18:32 UTC

Achiziții, Fuziuni, Preluări

Waters Corp. Deal for Becton Dickinson Unit a Long-Term Play With Some Risks -- Analysis

15 iul. 2025, 18:31 UTC

Achiziții, Fuziuni, Preluări

Waters Deal for Becton Unit Pairs Near-Term Risks With Possible Long-Term Rewards, Analysts Say

14 iul. 2025, 16:53 UTC

Acțiuni populare

Stocks to Watch Monday: Kenvue, Tesla, Synopsys, Robinhood -- WSJ

14 iul. 2025, 16:12 UTC

Market Talk

Achiziții, Fuziuni, Preluări

Waters Closer to Thermo Fisher, Danaher With Becton Dickinson Unit -- Market Talk

14 iul. 2025, 15:06 UTC

Achiziții, Fuziuni, Preluări

Waters Stock Is Falling on Deal to Combine With Becton Dickinson Unit -- Barrons.com

14 iul. 2025, 14:11 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson Biosciences & Diagnostics Unit to Merge With Waters Corp. in $17.5B Deal -- 2nd Update

14 iul. 2025, 10:53 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal -- Update

14 iul. 2025, 10:22 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson Unit to Combine With Waters Corp. in $17.5B Deal

14 iul. 2025, 10:22 UTC

Achiziții, Fuziuni, Preluări

Waters To Assume About $4 Billion Incremental Debt >WAT BDX

14 iul. 2025, 10:22 UTC

Achiziții, Fuziuni, Preluări

Becton Dickinson to Get $4 Billion Cash Distribution Prior to Closing >WAT BDX

14 iul. 2025, 10:21 UTC

Achiziții, Fuziuni, Preluări

Waters Holders to Own 60.8% of Combined Company, Becton Dickinson Holders to Own 39.2% >WAT BDX

14 iul. 2025, 10:20 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson: Combined Company to Have About $9 Billion Revenue, $3.3 Billion Adjusted Ebitda >WAT

14 iul. 2025, 10:19 UTC

Achiziții, Fuziuni, Preluări

Correct: Waters, Becton Dickinson See About $290 Million Revenue Synergies by Year Five >WAT BDX

14 iul. 2025, 10:19 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson See About $345 Million Annualized Ebitda Synergies by 2030 >WAT BDX

14 iul. 2025, 10:18 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson See About $290 Revenue Cost Synergies by Year Five >WAT BDX

14 iul. 2025, 10:18 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson See About $200 Million Cost Synergies by Year Three >WAT BDX

14 iul. 2025, 10:17 UTC

Achiziții, Fuziuni, Preluări

Waters: Becton Dickinson Deal Doubles Total Addressable Market to About $40 Billion >WAT

14 iul. 2025, 10:16 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson Deal Structured as Reverse Morris Trust >WAT BDX

14 iul. 2025, 10:16 UTC

Achiziții, Fuziuni, Preluări

Waters, Becton Dickinson Deal Valued at About $17.5 Billion >WAT BDX

14 iul. 2025, 10:15 UTC

Achiziții, Fuziuni, Preluări

Waters to Combine With Becton Dickinson's Biosciences & Diagnostic Solutions Business >WAT BDX

14 iul. 2025, 10:15 UTC

Achiziții, Fuziuni, Preluări

Waters and BD's Biosciences & Diagnostic Solutions Business to Combine

Comparație

Modificare preț

Waters Corp Așteptări

Obiectiv de preț

By TipRanks

2.4% sus

Prognoză pe 12 luni

Medie 388.88 USD 2.4%

Maxim 440 USD

Minim 345 USD

În baza a 17 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruWaters Corp - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

17 ratings

Cumpărare

Păstrare

Vânzare

Ținând cont de 17 analiști care au acordat evaluări ale acțiunilor Waters Corp - Dist în ultimele 3 luni.

Sentiment

By Acuity

67 / 344 Clasament în Sănătate

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

Despre Waters Corp

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans. It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments. In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing. Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research. Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications. The company was founded in 1958 and is headquartered in Milford, Massachusetts.